The results suggested that PKP2/3 may affect the survival and prognosis of ovarian cancer by regulating the immune infiltration in tumor microenvironment, which can provide new directions and novel approach for immunotherapy of ovarian cancer. The gene discussed is PKP2; the disease is ovarian carcinoma.